The global Advanced Therapy Medicinal Products (ATMP) CDMO Market was valued at USD 5.65 billion in 2023 and is projected to grow significantly to USD 26.27 billion by 2032, exhibiting a CAGR of 18.8% during the forecast period. The sharp growth is fueled by the rapid commercialization of cell therapies, gene therapies, and tissue-engineered...